Mortality rate and acute kidney injury prevalence reduction in COVID‑19 critical patients treated with hemoperfusion
Introduction: Coronavirus disease 2019 (COVID‑19) induces organic damage mainly through the patient’s immune overreaction. Hemoperfusion (HPF) can remove infl ammatory cytokines and can reduce the negative effects of cytokine storm in COVID‑19. We compared the mortality rate, infl ammatory response,...
- Autores:
-
Barriga‑Moreno, Adriana P.
Lozano‑Sánchez, Marcela
Barón‑Álvarez, Rafael A.
Cordoba, Juan P.
Aroca‑Martínez, Gustavo
Dianda, Daniela
Gonzalez‑Torres, Henry
Musso, Carlos G.
- Tipo de recurso:
- Fecha de publicación:
- 2024
- Institución:
- Universidad Simón Bolívar
- Repositorio:
- Repositorio Digital USB
- Idioma:
- eng
- OAI Identifier:
- oai:bonga.unisimon.edu.co:20.500.12442/14485
- Acceso en línea:
- https://hdl.handle.net/20.500.12442/14485
- Palabra clave:
- Acute kidney injury
COVID‑19
Hemoperfusion
- Rights
- openAccess
- License
- Attribution-NonCommercial-NoDerivatives 4.0 Internacional